These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 14657626)

  • 41. Stromelysin-3 expression in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans: comparison with factor XIIIa and CD34.
    Kim HJ; Lee JY; Kim SH; Seo YJ; Lee JH; Park JK; Kim MH; Cinn YW; Cho KH; Yoon TY
    Br J Dermatol; 2007 Aug; 157(2):319-24. PubMed ID: 17596171
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CD99 expression in dermatofibrosarcoma protuberans and dermatofibroma.
    Kazlouskaya V; Malhotra S; Kabigting FD; Lal K; Elston DM
    Am J Dermatopathol; 2014 May; 36(5):392-6. PubMed ID: 24247571
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cellular fibrous histiocytoma of the skin: evidence of a clonal process with different karyotype from dermatofibrosarcoma.
    Vanni R; Marras S; Faa G; Licheri S; Daniele GM; Fletcher CD
    Genes Chromosomes Cancer; 1997 Apr; 18(4):314-7. PubMed ID: 9087573
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Role of CD34 and D2-40 in the Differentiation of Dermatofibroma and Dermatofibrosarcoma Protuberans.
    Sadullahoğlu C; Dere Y; Atasever TR; Öztop MT; Karaaslan Ö
    Turk Patoloji Derg; 2017; 1(1):223-227. PubMed ID: 28832078
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fibrohistiocytic Tumors.
    Romano RC; Fritchie KJ
    Clin Lab Med; 2017 Sep; 37(3):603-631. PubMed ID: 28802503
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recent advances in the diagnosis, classification and molecular pathogenesis of cutaneous mesenchymal neoplasms.
    Papke DJ; Hornick JL
    Histopathology; 2022 Jan; 80(1):216-232. PubMed ID: 34958499
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors. Dermatofibrosarcoma protuberans and giant cell fibroblastoma.
    Sandberg AA; Bridge JA
    Cancer Genet Cytogenet; 2003 Jan; 140(1):1-12. PubMed ID: 12550751
    [No Abstract]   [Full Text] [Related]  

  • 48. Ploidy analysis in paraffin-embedded malignant fibrous histiocytoma by DNA cytofluorometry and flourescence in situ hybridization.
    Murata H; Kusuzaki K; Hirasawa Y; Inazawa J; Abe T; Ashihara T
    Cancer Lett; 1997 Sep; 118(1):123-8. PubMed ID: 9310269
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dermatofibroma and dermatofibrosarcoma protuberans: differential expression of CD34 and factor XIIIa.
    Cohen PR; Rapin RP; Farhood AI
    Am J Dermatopathol; 1994 Oct; 16(5):573-4. PubMed ID: 7528477
    [No Abstract]   [Full Text] [Related]  

  • 50. Immunohistochemical observation of intracytoplasmic lysozyme in proliferative and neoplastic fibrohistiocytic lesions.
    Nakanishi S; Shinomiya S; Sano T; Hizawa K
    Acta Pathol Jpn; 1982 Nov; 32(6):949-59. PubMed ID: 6297236
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relevance of ploidy related parameters for prognosis in malignant fibrous histiocytomas.
    Brinck U; Korabiowska M; Buschmann N; Stachura J; Ruschenburg I; Cordon-Cardo C; Schauer A
    Anticancer Res; 1999; 19(6B):5211-6. PubMed ID: 10697537
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Microphthalmia-associated transcription factor (MiTF): Promiscuous staining patterns in fibrohistiocytic lesions is a potential pitfall.
    Mohanty SK; Sharma S; Pradhan D; Kandukuri SR; Farahani N; Barry C; Wu JM; Frishberg D; Balzer B
    Pathol Res Pract; 2018 Jun; 214(6):821-825. PubMed ID: 29773427
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The expression levels of thrombospondin-1 in dermatofibroma and dermatofibrosarcoma protuberans.
    Maekawa T; Jinnin M; Ohtsuki M; Ihn H
    Eur J Dermatol; 2011; 21(4):534-8. PubMed ID: 21697041
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparative study of Ki-67 immunostaining and nuclear DNA content in histiofibrous tumors.
    Ooe M; Nogita T; Kawashima M
    J Dermatol; 1992 Jan; 19(1):12-8. PubMed ID: 1317394
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 3D-Histological evaluation of surgery in dermatofibrosarcoma protuberans and malignant fibrous histiocytoma: differences in growth patterns and outcome.
    Häfner HM; Moehrle M; Eder S; Trilling B; Röcken M; Breuninger H
    Eur J Surg Oncol; 2008 Jun; 34(6):680-6. PubMed ID: 17716851
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diagnostic utility of ERG immunostaining in dermatofibroma.
    Yamada Y; Ichiki T; Susuki Y; Yamada-Nozaki Y; Tateishi Y; Furue M; Oda Y
    J Clin Pathol; 2023 Aug; 76(8):536-540. PubMed ID: 35318257
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunoexpression of ultraviolet photoproducts and p53 mutation analysis in atypical fibroxanthoma and superficial malignant fibrous histiocytoma.
    Sakamoto A; Oda Y; Itakura E; Oshiro Y; Nikaido O; Iwamoto Y; Tsuneyoshi M
    Mod Pathol; 2001 Jun; 14(6):581-8. PubMed ID: 11406660
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dermatofibrosarcoma protuberans in children: an update on the diagnosis and treatment.
    Kornik RI; Muchard LK; Teng JM
    Pediatr Dermatol; 2012; 29(6):707-13. PubMed ID: 22780227
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Giant cell fibroblastoma in a child misdiagnosed as a dermatofibroma.
    Nguyen CM; Burch JM; Fitzpatrick JE; Peterson SL; Weston WL
    Pediatr Dermatol; 2002; 19(1):28-32. PubMed ID: 11860566
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fat necrosis with an associated lymphocytic infiltrate represents a histopathologic clue that distinguishes cellular dermatofibroma from dermatofibrosarcoma protuberans.
    Schechter SA; Bresler SC; Patel RM
    J Cutan Pathol; 2020 Oct; 47(10):913-916. PubMed ID: 32412128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.